SCHEMBL1181973

SCHEMBL1181973

CCOC(=O)N1CCc2sccc2[C@@H](C)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 1/20 0.43
NOS1 P29475 1/20 0.43
NOS2 P35228 1/20 0.43
HHAT Q5VTY9 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HSD17B10 Q99714 1/20 0.42
BRD4 O60885 3/20 0.42
PKM P14618 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
ALDH1A1 P00352 2/20 0.39
LMNA P02545 1/20 0.39
PRMT5 O14744 1/20 0.39
WDR77 Q9BQA1 1/20 0.39
ABL1 P00519 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
RIN1 Q13671 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1181699 1.00 NOS3 (0.43) NOS3NOS1NOS2HHATSMN1; SMN2
SCHEMBL1181974 1.00 NOS3 (0.43) NOS3NOS1NOS2HHATSMN1; SMN2
SCHEMBL2994358 0.87 SMN1; SMN2 (0.42) NOS3NOS1NOS2HHATSMN1; SMN2
SCHEMBL2994354 0.87 SMN1; SMN2 (0.42) NOS3NOS1NOS2HHATSMN1; SMN2
SCHEMBL2994360 0.87 SMN1; SMN2 (0.42) NOS3NOS1NOS2HHATSMN1; SMN2
SCHEMBL3004324 0.86 NOS3 (0.42) NOS3NOS1NOS2HHATSMN1; SMN2
SCHEMBL3004323 0.86 NOS3 (0.42) NOS3NOS1NOS2HHATSMN1; SMN2
SCHEMBL3004325 0.86 NOS3 (0.42) NOS3NOS1NOS2HHATSMN1; SMN2
SCHEMBL2992673 0.85 BRD4 (0.43) NOS3NOS1NOS2HHATSMN1; SMN2
SCHEMBL2992674 0.85 BRD4 (0.43) NOS3NOS1NOS2HHATSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1981337-B1 THIOPHENYL AZEPINES AS SEROTONIN 5-HT2C RECEPTOR LIGANDS AND USES THEREOF ATHERSYS INC (US) 2015-09-02 EP disclosed
US-20140206672-A1 THIOPHENYL AND PYRROLYL AZEPINES AS SEROTONIN 5-HT2C RECEPTOR LIGANDS AND USES THEREOF ABT HOLDING COMPANY (US) 2014-07-24 US disclosed
US-8716276-B2 Thiophenyl and pyrrolyl azepines as serotonin 5-HT2C receptor ligands and uses thereof ATHERSYS, INC. (US) 2014-05-06 US disclosed
US-20110112072-A1 THIOPHENYL AND PYRROLYL AZEPINES AS SEROTONIN 5-HT2C RECEPTOR LIGANDS AND USES THEREOF TUMEY L NATHAN 2011-05-12 US disclosed
US-7893051-B2 Thiophenyl and pyrrolyl azepines as serotonin 5-HT2c receptor ligands and uses thereof ATHERSYS, INC. (US) 2011-02-22 US disclosed
US-20070191342-A1 Thiophenyl and pyrrolyl azepines as serotonin 5-HT2c receptor ligands and uses thereof ATHERSYS, INC. 2007-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112072-A1 THIOPHENYL AND PYRROLYL AZEPINES AS SEROTONIN 5-HT2C RECEPTOR LIGANDS AND USES THEREOF HTR2C, HTR5A, HTR2A NOS3 1373/4885NOS1 2092/4885NOS2 1114/4885
US-20140206672-A1 THIOPHENYL AND PYRROLYL AZEPINES AS SEROTONIN 5-HT2C RECEPTOR LIGANDS AND USES THEREOF HTR2C, HTR5A, HTR2A NOS3 1373/4885NOS1 2092/4885NOS2 1114/4885
US-20070191342-A1 Thiophenyl and pyrrolyl azepines as serotonin 5-HT2c receptor ligands and uses thereof HTR2C, HTR5A, HTR2A NOS3 1373/4885NOS1 2092/4885NOS2 1114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.